Authors also analyzed cohorts of ovarian, colon, bladder, prostate, and renal cancer patients and found that intraepithelial CD3+ or CD8+ cells correlated with significant increases in overall survival, and that high percentages of tumor vessels with FasL+ inversely correlated with intraepithelial CD3+ cells presence. This evidence concerns the gene CD8A and neoplasm.